Beijing Dingzhong Weikang Pharmaceutical Technology

Beijing Dingzhong Weikang Pharmaceutical Technology is a China-based biotechnology company specializing in the development of high-end complex formulations and long-acting drug delivery systems. The company leverages its proprietary microsphere and liposome technology platforms to create improved versions of existing therapeutic agents, primarily following the 505(b)(2) regulatory pathway. Its pipeline focuses on chronic diseases requiring long-term management, including psychiatric disorders, endocrine diseases, and oncology. By providing sustained-release injectable formulations, Dingzhong Weikang aims to significantly improve patient compliance and therapeutic efficacy compared to conventional dosing regimens.